Replies to post #754295 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

For all we know management could be leading the life of retirees just letting “Consultants” do the work. LP could be in London sipping tea while doing some light bookkeeping, and retail would never even know it. Honestly, I’be never seen anything like their behavior.

[improving]

Yet, Delve Insight has DCVax as the #1 treatment for GBM through 2030. (https://www.delveinsight.com/report-store/dcvax-l-emerging-drug-insight-and-market-forecast). Go figure.

Your comment that other approvals will take excessive time seems off the mark. Pharmaceutical companies with approved drugs may receive conditional approvals and accelerated pathways for other indications and combination therapies. Additional confirmatory trials typically do not involve reinventing the wheel.

Lastly, I'm curious about your knowledge of NorthWest's financial relationships with "big pharma". I'm guessing you're guessing. Here's what I do know:
Despite all the negativity posted 24/7 on this board, Northwest has a very loyal longstanding shareholder base, that seems to understand the science and broad potential of the DCVax platform. I doubt that will decline with the MHRA's upcoming approval decision.

You guys have been very busy lately.
_________________________
Be prepared for another lost decade...The problem is they don’t have a big pharma partner who is willing to...